267 results on '"Guryanova, Olga A."'
Search Results
2. Use of technogenic raw materials in ceramic technology
3. Use of Technogenic Raw Materials in the Technology of Ceramic Materials
4. CD70 CXCR2-Modified CAR T-Cells Against Acute Myeloid Leukemia
5. Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations
6. Technological Aspects of Obtaining Fuel Composites Based on Fine-Grained Coal Waste
7. Epigenetic Mechanisms in Hematologic Aging and Premalignant Conditions
8. HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia
9. Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer
10. Data from The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation
11. Supplementary Figure from The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation
12. Supplementary Data from The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation
13. Table S1 from Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers
14. Table S3 (part 3) from Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers
15. Data from Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers
16. Supplementary Figure S3 A-E from Defining ATM-Independent Functions of the Mre11 Complex with a Novel Mouse Model
17. Data from Defining ATM-Independent Functions of the Mre11 Complex with a Novel Mouse Model
18. Supplementary Figure S5 from Defining ATM-Independent Functions of the Mre11 Complex with a Novel Mouse Model
19. SUPPLEMENTARY MATERIALS from Defining ATM-Independent Functions of the Mre11 Complex with a Novel Mouse Model
20. Table S3 (part 1) from Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers
21. Supplementary Methods, Figure Legends, Table Legends, Figures S1 - S5 from Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers
22. Table S3 (part 2) from Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers
23. Supplementary Figure S3 F from Defining ATM-Independent Functions of the Mre11 Complex with a Novel Mouse Model
24. Supplementary Table from miR-196b–TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML
25. Supplementary Data from miR-196b–TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML
26. Data from miR-196b–TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML
27. Supplementary Data from DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication Forks
28. Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway
29. Fuel Briquettes Made of Carbon-Containing Technogenic Raw Materials
30. Hematopoietic-specific heterozygous loss ofDnmt3aexacerbates colitis-associated colon cancer
31. Study of the Dynamics and Diversity of Hematopoietic Stem Cells during Aging and Senolytic Drug Treatment Using Single Cell Transcriptomics
32. NPM1 Mutation Reprograms Leukemic Transcription Network Via Reshaping CTCF-Defined TAD Topology
33. NPM1 mutation reprograms leukemic transcription network via reshaping TAD topology
34. miR-196b–TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML
35. The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation
36. DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
37. The application of information technologies for color reproduction and technical system management in printing art production
38. The Cancer Stem Cell Paradigm
39. Repurposing Tranexamic Acid as an Anticancer Agent
40. DNMT3A with Leukemia-Associated R882 Mutations Promotes Fitness Advantage through Functional Heterogeneity within HSCs
41. Dnmt3a Mutations in the Hematopoietic System Promote Colitis-Associated Colon Cancer: A Model of Clonal Hematopoiesis in Solid Tumors
42. Nonreceptor Tyrosine Kinase BMX Maintains Self-Renewal and Tumorigenic Potential of Glioblastoma Stem Cells by Activating STAT3
43. DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication Forks
44. Repurposing Tranexamic Acid as an Anticancer Agent
45. 3015 – CLONAL HEMATOPOIESIS DRIVEN BY PARTIAL DNMT3A LOSS CONTRIBUTES TO AN AGGRESSIVE PHENOTYPE OF COLITIS-ASSOCIATED COLON CANCER
46. NPM1mutation reprograms leukemic transcription network via reshaping TAD topology
47. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
48. Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting
49. DNMT3A alterations associated with myeloid malignancies dictate differential responses to hypomethylating agents
50. Alterations to DNMT3A in Hematologic Malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.